The FASEB Journal · 2007 · 17 citations · 38 references
MedicineImmunologyOncologyAdaptive ImmunityCancer ImmunologyTumor ImmunologyAntigen DesignAntigen PresentationAntitumor T Cell ResponsesCancer ImmunotherapyCancer VaccinesVaccine Antigen DesignAdaptive Antitumor ImmunityAntigen-specific T Cell ResponsesAntitumor Immune ActivationCancer ImmunostimulationCancer Vaccine DesignPeptide VaccinationT-cell Mediated ImmunityTumor Lysate Vaccines
Chaperone proteins are effective antitumor vaccines when purified from a tumor source, some of which are in clinical trials. Such vaccines culminate in tumor-specific T cell responses, implicating the role of adaptive immunity. We have developed a rapid and efficient procedure utilizing an isoelectric focusing technique to obtain vaccines from tumor or normal tissues called chaperone-rich cell lysate (CRCL). Tumor-associated peptides, the currency of T cell-mediated anticancer immunity, are believed to be purveyed by chaperone vaccines. Our purpose was to demonstrate our ability to manipulate the peptide antigen repertoire of CRCL vaccines as a novel anticancer strategy. Our methods allow us to prepare "designer" CRCL, utilizing the immunostimulation activity and the carrying capacity of CRCL to quantitatively acquire and deliver exogenous antigenic peptides (e.g., derived from the oncogenic BCR/ABL protein in chronic myelogenous leukemia). Using fluorescence-based and antigen-presentation assays, we determined that significant quantities of exogenously added peptide could accumulate in "designer" CRCL and could stimulate T cell activation. Further, we concluded that peptide-embedded CRCL, devoid of other antigens, could generate potent immunity against pre-established murine leukemia. Designer CRCL allows for the development of personalized vaccines against cancers expressing known antigens, by embedding antigens into CRCL derived from normal tissue.
38
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Andrej Shevchenko, Matthias Wilm, Ole Vorm et al. · Analytical Chemistry · 1996 · 9.1K citations
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
Pierre van der Bruggen, Catia Traversari, Patrick Chomez et al. · Science · 1991 · 3.5K citations
Life Sciences, Immunology, Oncology +17
Nathalie E. Blachère, Zihai Li, Rajiv Y. Chandawarkar et al. · The Journal of Experimental Medicine · 1997 · 557 citations · Full text
Life Sciences, Immunology, Oncology +17
Linda M. Liau, Robert M. Prins, Sylvia M. Kiertscher et al. · Clinical Cancer Research · 2005 · 541 citations · Full text
Medicine, Immunology, Oncology +17